Literature DB >> 27585678

Sinusoidal obstruction syndrome in the animal model: influence on liver surgery.

Azin Jafari1, Sven Wehner1, Jörg C Kalff1, Steffen Manekeller2.   

Abstract

PURPOSE: In recent years, multimodal treatment approaches have led to an increased median survival time of patients with colorectal liver metastases. In particular, this results from new perioperative chemotherapy regimens, which in turn are accompanied by an increased risk of perioperative bleeding and/or liver failure due to the hepatotoxic side effects. Nineteen to 58 % of patients treated with oxaliplatin develop sinusoidal obstruction syndrome (SOS). The influence of preexisting SOS on liver surgery remains controversial.
METHODS: Animals were operated 4 days after SOS induction with monocrotaline and received either vascular occlusion in the form of Pringle maneuver (PM) or hepatectomy (LR; 70 %) or a combination of both (LR + PM). Postoperative liver function was assessed by determination of liver enzyme levels, bile production, and tissue oxygen saturation.
RESULTS: Preexisting SOS impaired morbidity after liver resection, reflected by elevated liver enzyme levels, reduced bile secretion, and low liver tissue oxygenation levels. Mortality was increased by up to 25 %. Additional ischemia in the form of PM showed no further impact in the LR ± PM group compared to LR alone.
CONCLUSION: PM without LR results in high enzyme distribution in the SOS group. SOS significantly affects the outcome after liver resection in our experimental rat model only without PM and showed no protective effect in ischemia in the form of PM.

Entities:  

Keywords:  Hepatectomy; Liver failure; Monocrotaline; Oxaliplatin; Pringle maneuver; Sinusoidal obstruction syndrome (SOS)

Mesh:

Substances:

Year:  2016        PMID: 27585678     DOI: 10.1007/s00423-016-1506-0

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  30 in total

1.  Sinusoidal obstruction syndrome (SOS): A light and electron microscopy study in human liver.

Authors:  C P H Vreuls; A Driessen; S W M Olde Damink; G H Koek; H Duimel; M A J van den Broek; C H C Dejong; F Braet; E Wisse
Journal:  Micron       Date:  2016-02-15       Impact factor: 2.251

Review 2.  Sinusoidal obstruction syndrome.

Authors:  Laura Rubbia-Brandt
Journal:  Clin Liver Dis       Date:  2010-11       Impact factor: 6.126

3.  Evaluation of chemotherapy-associated liver injury in patients with colorectal cancer liver metastases using indocyanine green clearance testing.

Authors:  Peter-Michael Krieger; Dietmar Tamandl; Beata Herberger; Peter Faybik; Edith Fleischmann; Judith Maresch; Thomas Gruenberger
Journal:  Ann Surg Oncol       Date:  2011-01-05       Impact factor: 5.344

4.  Characterization of a reproducible rat model of hepatic veno-occlusive disease.

Authors:  L D DeLeve; R S McCuskey; X Wang; L Hu; M K McCuskey; R B Epstein; G C Kanel
Journal:  Hepatology       Date:  1999-06       Impact factor: 17.425

5.  Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases.

Authors:  Thomas Aloia; Mylène Sebagh; Marylène Plasse; Vincent Karam; Francis Lévi; Sylvie Giacchetti; Daniel Azoulay; Henri Bismuth; Denis Castaing; René Adam
Journal:  J Clin Oncol       Date:  2006-11-01       Impact factor: 44.544

6.  Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy.

Authors:  Hiroshi Nakano; Elie Oussoultzoglou; Edoardo Rosso; Selenia Casnedi; Marie-Pierre Chenard-Neu; Patrick Dufour; Philippe Bachellier; Daniel Jaeck
Journal:  Ann Surg       Date:  2008-01       Impact factor: 12.969

7.  Effect of preoperative chemotherapy on liver resection for colorectal liver metastases.

Authors:  N N Mehta; R Ravikumar; C A Coldham; J A C Buckels; S G Hubscher; S R Bramhall; S J Wigmore; A D Mayer; D F Mirza
Journal:  Eur J Surg Oncol       Date:  2007-12-21       Impact factor: 4.424

8.  Extended liver resection after preoperative chemotherapy: influence on regeneration and endoplasmic reticulum stress response.

Authors:  Steffen Manekeller; Alexandra Seinsche; Maria Sioutis; Andreas Hirner
Journal:  Langenbecks Arch Surg       Date:  2008-08-08       Impact factor: 3.445

9.  Dai-kenchu-to attenuates rat sinusoidal obstruction syndrome by inhibiting the accumulation of neutrophils in the liver.

Authors:  Masato Narita; Etsuro Hatano; Nobuyuki Tamaki; Kenya Yamanaka; Atsuko Yanagida; Hiromitsu Nagata; Hiroyuki Asechi; Yasutsugu Takada; Iwao Ikai; Shinji Uemoto
Journal:  J Gastroenterol Hepatol       Date:  2009-06       Impact factor: 4.029

10.  [Influence of neoadjuvant chemotherapy on liver integrity and ischemic tolerance].

Authors:  S Manekeller; M Sioutis; A Hirner; T Minor
Journal:  Z Gastroenterol       Date:  2008-01       Impact factor: 2.000

View more
  2 in total

Review 1.  A Critical Analysis of Experimental Animal Models of Sinusoidal Obstruction Syndrome.

Authors:  Arvind Kumar; Richard Palek; Vaclav Liska
Journal:  J Clin Exp Hepatol       Date:  2018-07-17

2.  Bevacizumab exacerbates sinusoidal obstruction syndrome (SOS) in the animal model and increases MMP 9 production.

Authors:  Azin Jafari; Hanno Matthaei; Sven Wehner; Tolga Tonguc; Jörg C Kalff; Steffen Manekeller
Journal:  Oncotarget       Date:  2018-04-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.